Strategies for Pharmacist Involvement in Adverse Effect Management | PTCE Pharmacy Connect

Educational Objectives ·            Recognize best practices for managing adverse effects associated with immune checkpoint inhibitor (ICI)-targeted therapy combinations   Faculty: Jacob K. Kettle, PharmD, BCOP Pharmacy Manager Ellis Fischel Cancer Center Department of Pharmacy University of Missouri Health Care Columbia, Missouri   Faculty, has the following financial relationships with commercial interests to disclose: Jacob Kettle, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose: Speakers Bureau: Genentech, Merck, Amgen, Lilly, DSI Consultant: Pfizer, Lilly Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.075 CEU) under the ACPE universal activity number 0290-0000-21-438-H01-P. The activity is available for CE credit through December 17, 2022. This activity is supported by educational grants from Eisai Inc and Exelixis, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices